NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $208,257 | -1.2% | 2,134 | 0.0% | 0.05% | +3.8% |
Q2 2023 | $210,775 | -22.8% | 2,134 | -23.4% | 0.05% | -27.8% |
Q1 2023 | $273,084 | +4.1% | 2,786 | -2.2% | 0.07% | +1.4% |
Q4 2022 | $262,257 | +17.6% | 2,850 | -1.0% | 0.07% | +2.9% |
Q3 2022 | $223,000 | -9.7% | 2,880 | 0.0% | 0.07% | -4.2% |
Q2 2022 | $247,000 | -7.5% | 2,880 | -4.9% | 0.07% | +1.4% |
Q1 2022 | $267,000 | -4.6% | 3,029 | -3.5% | 0.07% | -2.7% |
Q4 2021 | $280,000 | -8.2% | 3,138 | -14.1% | 0.07% | -13.1% |
Q3 2021 | $305,000 | -17.1% | 3,655 | -9.6% | 0.08% | -20.0% |
Q2 2021 | $368,000 | +4.2% | 4,041 | -0.2% | 0.10% | -8.7% |
Q1 2021 | $353,000 | 0.0% | 4,050 | +2.6% | 0.12% | -4.2% |
Q4 2020 | $353,000 | +6.3% | 3,949 | -5.1% | 0.12% | -9.8% |
Q3 2020 | $332,000 | -2.1% | 4,162 | +1.1% | 0.13% | -2.9% |
Q2 2020 | $339,000 | -4.5% | 4,116 | +2.2% | 0.14% | -22.6% |
Q1 2020 | $355,000 | -7.1% | 4,026 | -1.2% | 0.18% | +4.1% |
Q4 2019 | $382,000 | +8.2% | 4,076 | +5.5% | 0.17% | -1.2% |
Q3 2019 | $353,000 | – | 3,863 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |